RT Journal Article
SR Electronic
A1 Helwick, Caroline
T1 Fenofibrate Treatment and Renal Function in Type 2 Diabetes: FIELD Helsinki Substudy
JF MD Conference Express
YR 2007
FD SAGE Publications
VO 7
IS 6
SP 11
OP 11
DO 10.1177/155989770700700608
UL http://mdc.sagepub.com/content/7/6/11.1.abstract
AB Results from a substudy of Fenofibrate Intervention and Event Lowering in Diabetes [FIELD] study, the largest study of fibrates to date, showed no evidence for direct nephroprotection from fenofibrate use [The Field Study Investigators Lancet 2005]. There was, however, an increase in plasma creatinine.